Novartis is proud of its collaborations. Working together with the NHS, its staff and patient groups is vital for improving outcomes for patients and ensuring they receive the best possible care. Patients benefit from these collaborations with new and improved medicines, better services and care, and clinical teams that have benefited from education.
The disclosure of payments to individuals is an industry-led initiative, which Novartis fully supports and has fully complied with by providing the Association of British Pharmaceutical Industries (ABPI) with a list of payments to be published on their common platform, where all pharmaceutical company payments to individuals and healthcare organisations in the UK are listed.
Transparency across the public sector, including healthcare, is increasingly being demanded by the general public. Novartis has made every effort to encourage all individuals to disclose details of their payments, and is committed to continuing working with all stakeholders to increase transparency around these relationships.
We believe that open communication about these interactions helps foster trust with patients, the NHS, and the public, and we are dedicated to full transparency. We are committed to working with integrity, upholding high ethical standards, and following all laws and regulations.
The Pharmaceuticals division of Novartis has published the following sponsorship, grants and service payments in 2014
Sponsorship for attendance at educational meetings organised by third parties during 2014 • Novartis Pharmaceuticals provided £758 497.86 as total sponsorship funding of 399 attendances at third party meetings, congresses and conferences for a total of 383 recipients.
Engagement of healthcare professionals to provide consultancy services during 2014 • Novartis Pharmaceuticals engaged 783 healthcare professionals to provide consultancy services at a total cost of £1 427 465.38. These figures include both honoraria payments and associated costs relating to accommodation (UK and overseas) and overseas travel. This figure is inclusive of engagements with Novartis outside of the UK.
Medical educational and goods grants given during 2014 • Novartis Pharmaceuticals gave 60 grants with a total value of £1 739 094.44 to UK organisations, institutions and associations. Novartis Grants 2014